3
In June 2021, Tata Digital, a wholly owned subsidiary of the Tata group, acquired a majority stake in the online pharmacy 1mg (now Tata 1mg). The deal, worth $220-240 Mn for an estimated 51-60% stake, was a mix of primary infusion and secondary buyouts. It pegged the healthtech platform’s valuation at about $450 Mn, nearly double its pre-acquisition worth.
The deal was a strategic anchor for the Tata group’s digital health ambitions. In fact, 1mg’s e-pharmacy, diagnostics and telehealth services were positioned as a significant value…
